BrainStorm to Present NurOwn® Phase 3 Study Update at the 9th Annual California ALS Research Summit in Irvine, CA
Dr. Ralph Kern to Provide Update on the Phase 3 Pivotal Trial of Autologous MSC-NTF Cellular Therapy (NurOwn®) in ALS […]
Dr. Ralph Kern to Provide Update on the Phase 3 Pivotal Trial of Autologous MSC-NTF Cellular Therapy (NurOwn®) in ALS […]
VANCOUVER, British Columbia, Jan. 10, 2019 (GLOBE NEWSWIRE) — Abattis Bioceuticals Corp (the “Company” or “Abattis”) (CSE:ATT) (OTC:ATTBF) is pleased to […]
Aurora, IL, Jan. 10, 2019 (GLOBE NEWSWIRE) — Cabot Microelectronics Corporation (Nasdaq: CCMP), a leading global supplier of consumable materials […]
ANTIGONISH, Nouvelle-Écosse, 11 janv. 2019 (GLOBE NEWSWIRE) — Biome Grow Inc. (« Biome » ou la « Société ») (CSE […]
ANTIGONISH, Nova Scotia (Kanada), Jan. 11, 2019 (GLOBE NEWSWIRE) — Biome Grow Inc. („Biome“ oder das „Unternehmen“) (CSE: BIO) (Frankfurt: […]
Revenue increased by 16.3% (14.2% in constant currency(1)), to reach $643.3 million; Adjusted EBITDA(1) increased by 15.7% (13.8% in constant […]
Increases Common Share Dividend for the 26TH Consecutive Year CALGARY, Alberta, Jan. 10, 2019 (GLOBE NEWSWIRE) — The Board of […]
CALGARY, Alberta, Jan. 10, 2019 (GLOBE NEWSWIRE) — (TSX: CIU.PR.A, CIU.PR.C) The Board of Directors of CU Inc. has declared […]
Increases Common Share Dividend for the 47th consecutive year and announces suspension of the Dividend Reinvestment Program CALGARY, Alberta, Jan. […]
Revenue increased by 15.1% (13.1% in constant currency(1)), to reach $674.0 million; Adjusted EBITDA(1) increased by 15.0% (13.1% in constant […]